Heme Arginate Therapy forBeta Thalassemia:In vitro versus in vivo Effects

Publisher： Karger

E-ISSN： 1421-9662|100|2|82-84

ISSN： 0001-5792

Source： Acta Haematologica, Vol.100, Iss.2, 1998-10, pp. : 82-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neutrophil Activation in Severe, Early-Onset COPD Patients versus Healthy Non-Smoker Subjects in vitro: Effects of Antioxidant Therapy

By  

Respiration, Vol. 83, Iss. 2, 2011-11 ,pp. : 147-158

Karger

Access to resources Recommend Favorite

Cytokine-Induced Apoptosis of Beta-Thalassemia/Hemoglobin E Erythroid Progenitor Cells via Nitric Oxide-Mediated Process in vitro

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 224-230

Karger

Access to resources Recommend Favorite

Paradoxically Increased Ferritin Level in a Beta-Thalassemia Major Patient following the Start of Deferasirox Chelation Therapy

By  

Acta Haematologica, Vol. 123, Iss. 2, 2010-01 ,pp. : 117-120

Karger

Access to resources Recommend Favorite

Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox

By  

Acta Haematologica, Vol. 123, Iss. 3, 2010-02 ,pp. : 148-152

Karger

Access to resources Recommend Favorite

Evaluation of the Incidence of Sensorineural Hearing Loss in Beta-Thalassemia major Patients under Regular Chelation Therapy with Desferrioxamine

By  

Acta Haematologica, Vol. 108, Iss. 2, 2002-08 ,pp. : 79-83

Karger

Access to resources Recommend Favorite